Researchers compared people prescribed GLP-1 receptor agonists with those taking other diabetes drugs or no such medications
Bushnell also noted the ability of GLP-1 receptor agonists to decrease blood pressure and to decrease plaque formation associated with atherosclerosis, which is a risk factor for heart attack and stroke
Sources Phase 2 trial (NEJM) NEJM TRIUMPH-4 results Eli Lilly Related reading Retatrutide Dosage & Dosing Guide: Titration, Missed Doses, Taper Phase 3 titration schedule (246912 mg), missed-dose protocol, taper guidance, and dose-by-dose weight loss data
They also have protective effects on the liver in cases of alcohol-related liver disease, MASLD, and NASH, with a relative risk of 2.48 for resolving NASH
Para evitar complicaciones, se deben seguir las indicaciones del mdico